All News

Here’s a roundup of the latest coronavirus-related news:

The National Association of Chain Drug Stores and the National Forum for Heart Disease & Stroke Prevention released a video urging Americans to receive flu vaccinations.

The FDA is not required to follow the committee's advice, but it is expected to do so.

SCOTUS' decision upholds an Arkansas law regulating PBMs’ drug reimbursement rates.

Award winning actor Tom Hanks addressed pharmacists during the ASHP Midyear 2020 Clinical Meeting & Exhibition.

Each year, Drug Topics® surveys pharmacists on important workplace issues—from compensation encompassing salary, wages, and raises to stress levels and overall job satisfaction.

Here’s a roundup of the latest coronavirus-related news.

CVS Health will pilot the administration of a limited supply of the monoclonal antibody therapy bamlanivimab to eligible patients at home or in long-term care facilities.

A survey conducted by the American Pharmacists Association asked pharmacists if they were ready to receive and administer COVID-19 vaccines.

The clinics integrate pharmacists as critical members of VillageMD’s physician-led, multidisciplinary team.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Moderna reported an efficacy rate of 94.1% for its COVID-19 vaccine based on the primary efficacy analysis.

A recent study showed “alarming” rates of reported loneliness, anxiety, depression, and substance use in young adults during COVID-19.

Here’s a roundup of this week’s coronavirus-related news.

As coronavirus disease 2019 (COVID-19) cases rise across the country, members of the MJH Life Sciences COVID-19 Coalition shared their perspectives on pandemic containment efforts.

Lumasiran (Oxlumo; Alnylam Pharmaceuticals) is the first drug approved for the treatment of primary hyperoxaluria type 1, a rare genetic disorder.

The new model will test a new way to lower increasing drug prices for patients paying for drugs under Medicare Part B.

One vaccine dosing regimen for AZD1222 showed 90% efficacy, according to investigators at the University of Oxford.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Here's the roundup of this week's coronavirus-related news.

Results from the NIAID-sponsored ACTT-2 trial showed that COVID-19 patients treated with baricitinib in combination with remdesivir experienced better recovery times and clinical status.

Pfizer and BioNTech expect to produce up to 50 million doses globally in 2020 and up to 1.3 billion doses by the end of 2021.

The Department of Health and Human Services recently released a final rule requiring health insurers to disclose drug pricing and cost-sharing information

Pfizer and BioNTech today announced that their COVID-19 vaccine candidate showed a 95% efficacy rate in the final analysis of its phase 3 study.

Community non-profits receive funding to support health equity, healthcare providers, and rural communities.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

As part of a new partnership with HHS, the nation’s largest pharmacy chains—as well as independents and regional chains—will be administering free coronavirus disease 2019 (COVID-19) vaccines when they are available.

AmerisourceBergen has reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC) to include Good Neighbor Pharmacy and Elevate Provider Network members in the Federal Pharmacy Partnership Strategy for COVID-19 Vaccination.